LEMTRADA (2.1) - Sanofi
FULL PRESCRIBING INFORMATION WARNING: AUTOIMMUNITY, INFUSION REACTIONS, AND MALIGNANCIES • LEMTRADA causes serious, sometimes fatal, autoimmune conditions such as immune thrombocytopenia and anti-glomerular basement membrane disease.
Download LEMTRADA (2.1) - Sanofi
Information
Domain:
Source:
Link to this page:
Documents from same domain
HIGHLIGHTS OF PRESCRIBING INFORMATION …
products.sanofi.usHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KEVZARA® safely and effectively. See full prescribing information for KEVZARA.
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
products.sanofi.us• To minimize the risk of hypoglycemia, titrate the dose of TOUJEO no more frequently than every 3 to 4 days. • Dosage adjustments may be needed with changes in physical activity, changes in meal patterns
HIGHLIGHTS OF PRESCRIBING INFORMATION …
products.sanofi.usHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AUBAGIO® safely and effectively. See full prescribing information for AUBAGIO.
HIGHLIGHTS OF PRESCRIBING INFORMATION ... - …
products.sanofi.usHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT.
HIGHLIGHTS OF PRESCRIBING INFORMATION Depression ...
products.sanofi.usHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to useAMBIEN safely and effectively. See full prescribing information for AMBIEN
RIFADIN Rx Only Plasma concentrations after the 600 mg ...
products.sanofi.usRIFADIN® Rx Only (rifampin capsules USP) and RIFADIN® IV (rifampin for injection USP) To reduce the development of drug-resistant bacteria and maintain the effectiveness of
HIGHLIGHTS OF PRESCRIBING INFORMATION Infusion …
products.sanofi.usHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Fabrazyme safely and effectively. See full prescribing information for Fabrazyme.
HIGHLIGHTS OF PRESCRIBING INFORMATION Need to …
products.sanofi.usThe effect of AMBIEN may be slowed by ingestion with or immediately after a meal. 3 DOSAGE FORMS AND STRENGTHS AMBIEN is available in 5 mg and 10 mg strength tablets for oral administration. Tablets are not scored. AMBIEN 5 mg tablets are capsule-shaped, pink, film coated, with AMB 5 debossed on one side and 5401 on the other.
HIGHLIGHTS OF PRESCRIBING INFORMATION : Discontinue ...
products.sanofi.us• Maximum daily dosage is 60 units (60 units of insulin glargine and 20 mcg of lixisenatide). (2.1) • Discontinue basal insulin or GLP-1 receptor agonist prior to initiation. (2.2) • In patients naive to basal insulin or to a GLP-1 receptor agonist, currently on less than 30 units of basal insulin, or on a GLP-1 receptor agonist, the ...
Single-dose prefilled syringes: 30 mg/0.3 mL, 40 ... - Sanofi
products.sanofi.usanesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures. Factors that can increase the risk of developing epidural or spinal hematomas in these patients include: • Use of indwelling epidural catheters